文献速递肿瘤 PET/CT核素与放射性配体治疗

口服谷氨酸钠对前列腺癌患者68Ga-PSMA-11生物分布的影响:前瞻性随机对照显像研究

The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study.
PubMed 文献 · J Nucl Med · 2021-01-28

结果显示口服MSG使唾液腺SUVmean和SUVmax平均分别下降45%±15%(P=0.004)和53%±11%(P<0.001),肿瘤病灶SUVmean和SUVmax亦分别下降38%(四分位距-67%至-33%)和-52%(四分位距-70%至-49%)(P=0.018);含漱对正常器官及肿瘤摄取无显著影响。

要点

  • 口服MSG可显著降低唾液腺68Ga-PSMA-11摄取,但肿瘤摄取同步下降。
  • 口腔含漱MSG对正常器官及肿瘤的68Ga-PSMA-11摄取无显著影响。
  • 因肿瘤摄取亦下降,MSG在放射性配体治疗框架中临床价值有限。

核心结论

  • 口服摄入MSG而非局部含漱可降低唾液腺68Ga-PSMA-11摄取,但肿瘤摄取同时下降,故MSG在RLT框架中临床价值有限。

研究设计与样本

  • 每例受试者在14天内于基线和MSG条件下各接受一次68Ga-PSMA-11 PET/CT,使用qPSMA软件分割唾液腺和全身肿瘤病灶。
  • 通过SUVmean和SUVmax量化示踪剂摄取,并在每例患者内比较参数。

主要发现

  • 口服摄入组唾液腺SUVmean从对照扫描至MSG扫描平均下降45%±15%(P=0.004)。
  • 口服摄入组唾液腺SUVmax平均下降53%±11%(P<0.001)。
  • 口服摄入组肿瘤病灶SUVmean下降38%(四分位距-67%至-33%),SUVmax下降-52%(四分位距-70%至-49%)(P=0.018)。
  • 含漱对正常器官或肿瘤病灶的68Ga-PSMA-11蓄积无显著影响。

临床怎么用

  • 基于本研究,口服MSG虽可降低唾液腺摄取,但肿瘤摄取亦下降,因此不支持将其用于RLT框架下减少口干。
  • 口腔含漱MSG对68Ga-PSMA-11生物分布无显著影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prostate-specific membrane antigen (PSMA) has been targeted for PET imaging and radioligand therapy (RLT) in patients with prostate cancer. Xerostomia is a common side effect of RLT because of the high salivary gland uptake of PSMA radioligands. Here, we aimed to determine the impact of monosodium glutamate (MSG) administration on PSMA-radioligand biodistribution within healthy organs and tumor lesions by using 68Ga-PSMA-11 PET imaging. Methods: Sixteen men with prostate cancer were randomized (1:1) into oral ingestion and oral topical application ("swishing") arms. Each subject underwent 2 68Ga-PSMA-11 PET/CT scans within 14 d under baseline and MSG conditions. The salivary glands and whole-body tumor lesions were segmented using qPSMA software. We quantified tracer uptake via SUVmean and SUVmax and compared parameters within each patient. Results: For the oral ingestion arm, salivary gland SUVmean and SUVmax decreased on average from the control scan to the MSG scan by 45% ± 15% (P = 0.004) and 53% ± 11% (P < 0.001), respectively. Tumor lesion SUVmean and SUVmax also decreased by 38% (interquartile range, -67% to -33%) and -52% (interquartile range, -70% to -49%), respectively (P = 0.018). Swishing had no significant effect on 68Ga-PSMA-11 accumulation in normal organs or tumor lesions. Conclusion: Oral ingestion but not topical application of MSG reduced 68Ga-PSMA-11 uptake in salivary glands. Tumor uptake also declined; therefore, the clinical application of MSG is unlikely to be useful in the framework of RLT.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Armstrong WR, Gafita A, Zhu S, et al. The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study. J Nucl Med. 2021. PMID: 33509974. doi:10.2967/jnumed.120.257931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。